261 related articles for article (PubMed ID: 17011208)
41. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
[TBL] [Abstract][Full Text] [Related]
42. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
43. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
Cafferty WB; Duffy P; Huebner E; Strittmatter SM
J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
[TBL] [Abstract][Full Text] [Related]
44. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
45. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
[TBL] [Abstract][Full Text] [Related]
46. Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth.
Wang X; Budel S; Baughman K; Gould G; Song KH; Strittmatter SM
J Neurotrauma; 2009 Jan; 26(1):81-95. PubMed ID: 19125588
[TBL] [Abstract][Full Text] [Related]
47. Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration.
Llorens F; Gil V; del Río JA
FASEB J; 2011 Feb; 25(2):463-75. PubMed ID: 21059749
[TBL] [Abstract][Full Text] [Related]
48. Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats.
Nishio Y; Koda M; Kitajo K; Seto M; Hata K; Taniguchi J; Moriya H; Fujitani M; Kubo T; Yamashita T
Exp Neurol; 2006 Aug; 200(2):392-7. PubMed ID: 16624299
[TBL] [Abstract][Full Text] [Related]
49. LINGO-1 shRNA Loaded by Pluronic F-127 Promotes Functional Recovery After Ventral Root Avulsion.
Ding L; Zhu Z; Wang Y; Zeng L; Wang T; Luo J; Zou TB; Li R; Sun X; Zhou G; Liu X; Wu HF
Tissue Eng Part A; 2019 Oct; 25(19-20):1381-1395. PubMed ID: 30794055
[TBL] [Abstract][Full Text] [Related]
50. Lentiviral mediated expression of a NGF-soluble Nogo receptor 1 fusion protein promotes axonal regeneration.
Zhang Y; Gao F; Wu D; Moshayedi P; Zhang X; Ellamushi H; Yeh J; Priestley JV; Bo X
Neurobiol Dis; 2013 Oct; 58():270-80. PubMed ID: 23811498
[TBL] [Abstract][Full Text] [Related]
51. 17β-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury.
Lee JY; Choi SY; Oh TH; Yune TY
Endocrinology; 2012 Aug; 153(8):3815-27. PubMed ID: 22700771
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
Zhang Y; Zhang YP; Pepinsky B; Huang G; Shields LB; Shields CB; Mi S
Exp Neurol; 2015 Apr; 266():68-73. PubMed ID: 25681574
[TBL] [Abstract][Full Text] [Related]
53. Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats.
Wu BQ; Bi ZG; Qi Q
Chin Med J (Engl); 2013; 126(19):3723-7. PubMed ID: 24112171
[TBL] [Abstract][Full Text] [Related]
54. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
[TBL] [Abstract][Full Text] [Related]
55. The effects of N-acetyl-cysteine and acetyl-L-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury.
Karalija A; Novikova LN; Kingham PJ; Wiberg M; Novikov LN
Neuroscience; 2014 Jun; 269():143-51. PubMed ID: 24680856
[TBL] [Abstract][Full Text] [Related]
56. Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons.
Zhao XH; Jin WL; Wu J; Mi S; Ju G
Cell Mol Neurobiol; 2008 Aug; 28(5):727-35. PubMed ID: 18183482
[TBL] [Abstract][Full Text] [Related]
57. Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion.
Wang X; Yigitkanli K; Kim CY; Sekine-Komo T; Wirak D; Frieden E; Bhargava A; Maynard G; Cafferty WB; Strittmatter SM
J Neurotrauma; 2014 Dec; 31(24):1955-66. PubMed ID: 24964223
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery.
Figueroa JD; Benton RL; Velazquez I; Torrado AI; Ortiz CM; Hernandez CM; Diaz JJ; Magnuson DS; Whittemore SR; Miranda JD
J Neurosci Res; 2006 Nov; 84(7):1438-51. PubMed ID: 16983667
[TBL] [Abstract][Full Text] [Related]
59. RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury.
Xing B; Li H; Wang H; Mukhopadhyay D; Fisher D; Gilpin CJ; Li S
Exp Neurol; 2011 Oct; 231(2):247-60. PubMed ID: 21781963
[TBL] [Abstract][Full Text] [Related]
60. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.
Palandri A; Salvador VR; Wojnacki J; Vivinetto AL; Schnaar RL; Lopez PH
Cell Death Dis; 2015 Sep; 6(9):e1876. PubMed ID: 26335717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
